Increased secretion of type beta transforming growth factor accompanies viral transformation of cells
about
Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cellsReduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesisDifferential response to retinoic acid of Syrian hamster embryo fibroblasts expressing v-src or v-Ha-ras oncogenesEpidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts.Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-beta 1 (Ser223, 225).Transforming growth factors-beta 1 and beta 2 are mitogens for rat Schwann cells.Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines.Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogeneChemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression.Transforming growth factor beta1 (TGF-beta1) is a preoperative prognostic indicator in advanced gastric carcinomaDistribution and modulation of the cellular receptor for transforming growth factor-betaOsteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro.Dexamethasone-dependent inhibition of differentiation of C2 myoblasts bearing steroid-inducible N-ras oncogenes.Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes.Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome.TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan.Transforming growth factor-beta: possible roles in carcinogenesis.Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1Characterization of the mouse transforming growth factor-beta 1 promoter and activation by the Ha-ras oncogene.Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease.Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft modelEpidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells.Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex.The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation.Rapid and selective alterations in the expression of cellular genes accompany conditional transcription of Ha-v-ras in NIH 3T3 cells.Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factorDeconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression.Transcriptional control of expression of the TGF-betas.Growth factors in cancer and their relationship to oncogenes.Transforming growth factors in the regulation of malignant cell growth and invasion.Control of myogenic differentiation by cellular oncogenes.Malignant transformation of murine fibroblasts by a human c-Ha-ras-1 oncogene does not require a functional epidermal growth factor receptorReversible abrogation of IL-3 dependence by an inducible H-ras oncogene.Transforming growth factor-beta expression in mouse lung carcinogenesis.Transformed rat tracheal epithelial cells exhibit alterations in transforming growth factor-beta secretion and responsiveness.Oncogenes as inducers of tumor angiogenesis.Cloning and overexpression of TGF-beta 1 cDNA in a mammary adenocarcinoma: in vitro and in vivo effects.Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition.
P2860
Q28305879-B42A99C8-9A97-485A-AF65-42F9E7308E58Q28509893-4C1CB699-D508-4146-B7E2-DC886E0FA6E3Q30449954-76C77B1E-7234-49B9-B50E-42486352C645Q33931382-A93038C4-D84F-4D11-8884-24613DC23E87Q33937674-09B1F0A4-A249-4666-B4D5-2B8F3B6B3BB0Q34457404-0A8BD91A-9A7C-4028-820D-2D113FA38D00Q34568531-A960B7DB-F8EB-41A4-9C22-E67617970FC9Q34593947-AA2C07A3-0899-48AD-9FB2-EEE7E5496B77Q35490960-4AA31B18-937D-44F8-B608-3C693872B349Q35984169-A78A304A-1D55-46DD-81A5-D04440F1B107Q36029130-18D47F19-EAA9-4025-BAC1-60E76CAF0A31Q36115650-2E5ECBC6-D262-4C6C-BE8B-E97BBB0A7E4AQ36217344-95A4C2CA-DEBD-402A-9DDD-81F8782A6D94Q36218063-CA9B4A3C-D022-42D7-9B9E-BD415CE0F6B4Q36218963-DD941ADA-B554-45EE-828F-18B70A2612CFQ36220190-73308D02-9315-4705-B795-5D04C111EC7AQ36360983-8865473D-0D28-453F-8AE3-CCAF17DFF38AQ36383241-8A0A9213-0FD7-484E-94BE-7FA77BAE511EQ36465897-ECC57AC9-7449-45CF-B41D-5C6E35FC510AQ36531643-A3B04F97-262C-40B0-8E3D-01DAD78BB4A1Q36679595-34D94C16-F802-408D-BBBC-A20DDE9A0184Q36682869-BE3DD0F1-6A87-49C7-AE61-DBEE89F14FECQ36718776-2A88E4D2-3C22-4D9E-8D04-57F6074673B6Q36719220-8F077FDF-1944-43A9-B94A-5CEEE40412C0Q36755274-51545EE0-86F9-48C3-A4F3-F825D20DBF0DQ36841835-1B592F4E-E65C-47BC-BA17-C52CDD763038Q36843660-C9E7C8DD-1C35-4807-B5B9-05129EDD10B5Q36910988-14A66AC9-1FD6-4693-8A6E-FE3EDF80C562Q37044614-FFE06B81-36E9-4716-997E-55DBA6360367Q37943210-A6AD6490-9141-4345-AF5F-56B9F4CAD5CBQ39500167-CEE1740A-940A-4C68-ADAD-9FC669F8D5C4Q39573228-79FE7B12-1D8D-4D2A-95A0-40889726011BQ39581697-2298D2E4-A22D-4F60-9A45-986D8C368948Q40667295-7F5CC276-DE22-4F51-8ED2-E6E98D1B7B8BQ40819083-4B08281E-6940-4DB7-8AAB-98956D3C9F21Q41026603-961E73B2-09F9-4B96-9AC2-7DAB959CE86EQ41082934-948E364A-4B98-4468-B851-BC18F7198F92Q41121027-9309F58C-97C5-440C-8E17-2C47DE73DC6AQ41147284-09AB49C7-A25D-406B-9388-41D25D11BBFFQ41183989-AA880C51-76BD-4CCA-90ED-5C98D12F5D7B
P2860
Increased secretion of type beta transforming growth factor accompanies viral transformation of cells
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Increased secretion of type be ...... viral transformation of cells
@en
type
label
Increased secretion of type be ...... viral transformation of cells
@en
prefLabel
Increased secretion of type be ...... viral transformation of cells
@en
P2093
P2860
P356
P1476
Increased secretion of type be ...... viral transformation of cells
@en
P2093
Assoian RK
De Larco JE
Lazarus JE
Roberts AB
Wakefield LM
P2860
P304
P356
10.1128/MCB.5.1.242
P407
P577
1985-01-01T00:00:00Z